Home Compliance NJ Biopharma Company Settles FCA/AKS Case for $5M+ ComplianceDOJFCANews NJ Biopharma Company Settles FCA/AKS Case for $5M+ July 26, 2024 10 Share FacebookLinkedinTwitter Vitalii Vodolazskyi | Shutterstock You must be a Paid or Free Trial Member to Access this Content. Paid members, please login to view your news subscription(s). RELATED ARTICLESMORE FROM AUTHOR Development Special Alert – Chemonics to pay $3.1 Million to Resolve Allegations of Fraudulent Billing under Supply Chain Contract Cyber US Considers Banning TP-Link Routers Over Cybersecurity Risks Compliance Update Regarding Nationwide Injunction Pausing Implementation of the Corporate Transparency Act
